EW COURT NOTICE: Edwards Lifesciences Investors with Losses are Notified of December 13 Court Deadline in Securities Fraud Class Action – Contact BFA Law (NYSE:EW)
December 06, 2024 08:21 ET
|
Bleichmar Fonti & Auld
Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024 legal deadline.
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Edwards Lifesciences Corporation (NYSE: EW); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel
October 23, 2024 17:21 ET
|
DiCello Levitt LLP
SAN DIEGO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired Edwards Life Sciences Corporation. (NYSE:...
Aortic Valve Replacement Devices Market worth $18.07 Billion by 2030 - Exclusive Report by The Insight Partners
August 31, 2023 09:56 ET
|
The Insight Partners
Pune, India, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Aortic valve repair and aortic valve replacement are methods that treat diseases affecting the aortic valve. The aortic valve is one of four valves...
Transcatheter Heart Valve Replacement Repair Market Size Will Attain US$ 25.5 Billion by 2033 at a CAGR of 13.0% | Persistence Market Research
March 01, 2023 09:30 ET
|
Persistence Market Research
New York, March 01, 2023 (GLOBE NEWSWIRE) -- The global Transcatheter Heart Valve Replacement Repair Market is currently valued at around US$ 7.5 Billion in 2023. Sales of the market are set to...
Aortic Valve Replacement Market Size is projected to reach USD 33.51 Billion by 2030, growing at a CAGR of 14%: Straits Research
June 21, 2022 09:00 ET
|
Straits Research
New York, United States, June 21, 2022 (GLOBE NEWSWIRE) -- The main thing driving the aortic valve replacement market is the growing number of valvular diseases like aortic stenosis and aortic...
Transcatheter Aortic Valve Replacement/Implantation Market Expected To Rise By 2026, Estimates DelveInsight
February 04, 2021 20:20 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Transcatheter Aortic Valve Replacement/Implantation Market Expected To Rise By 2026, Estimates DelveInsight The rise in the prevalence of...
Colibri Heart Valve Receives a United States Patent Directed to a Replacement Heart Valve that Includes a Dry Valve Sutured to a Stent Member
September 24, 2019 16:01 ET
|
Colibri Heart Valve, LLC
BROOMFIELD, CO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that U.S. Patent No. 10,390,945 (“the ‘945 Patent”) was...
Colibri Heart Valve to Present Patient Follow-up Results from Clinical Feasibility Study of Second-Generation TAVI System at TCT
September 19, 2018 14:12 ET
|
Colibri Heart Valve, LLC
BROOMFIELD, CO , Sept. 19, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that results from the company’s international,...
Colibri Heart Valve Continues Enrollment in Clinical Feasibility Study of Second-Generation TAVI System
May 04, 2018 11:09 ET
|
Colibri Heart Valve, LLC
Broomfield, CO, May 04, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that the Colibri transcatheter aortic valve implantation...
Colibri Heart Valve Advances Second-Generation TAVI System into Clinical Feasibility Study
March 19, 2018 10:52 ET
|
Colibri Heart Valve, LLC
BROOMFIELD, CO , March 19, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that the first two patients have been successfully...